Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Leuk Res. 2014 Apr 12;38(7):773–780. doi: 10.1016/j.leukres.2014.04.001

Figure 2. Overall survival by age of diagnosis among all patients (2A) and of those alive/followed at 1 month (2B).

Figure 2

Figure 2

Patient age was significantly associated with overall survival among all patients with CBF-AML. Patient survival decreased with increasing age both at diagnosis (2A, P<0.0001) and among the subset of patients who were alive and followed after 1 month (2B, P<0.0001).